Oncology Supportive Care
Research activity includes symptom management for patients affected by chemotherapy-induced peripheral neuropathy, with attention to paresthesia such as numbness and tingling.
- Chemotherapy-related neuropathic symptoms
- Peripheral nerve toxicity
- Supportive cancer care
The clinical focus is on reducing sensory discomfort associated with cancer treatment and addressing its impact on daily functioning.
Neurological Symptom Relief
The sponsor’s trial portfolio centers on interventions for sensory neuropathy and related neuropathic symptoms that persist after anticancer therapy.
- Neuropathy-associated tingling
- Altered sensation
- Symptom burden
Interest is directed toward patient-reported changes in sensory symptoms and their effect on everyday comfort.
Quality of Life in Cancer Survivorship
Clinical research also addresses health-related quality of life in individuals living with persistent treatment-related nerve symptoms.
- Patient-reported outcomes
- Functional limitation
- Daily living impairment
This area reflects interest in how ongoing sensory discomfort influences well-being and routine activities after cancer therapy.
Integrative Symptom Management
Work at the hospital includes evaluation of adjunctive approaches for managing chemotherapy-induced neuropathy within routine clinical care.
- Adjunctive supportive interventions
- Non-pharmacological symptom care
- Refractory neuropathic discomfort
The research interest is concentrated on persistent sensory symptoms that remain despite standard management in oncology patients.
